| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |